| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $271.8M | +17.0% |
| Cost of Revenue | $77.5M | +18.9% |
| Gross Profit | $194.4M | +16.2% |
| R&D Expense | $36.3M | +19.1% |
| SG&A Expense | $61.3M | -5.6% |
| Operating Income | -$15.4M | +62.6% |
| Pre-tax Income | -$18.6M | +44.7% |
| Income Tax | $2.9M | -42.7% |
| Net Income | -$21.7M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $223.2M | -1.8% |
| Short-term Investments | $3.7M | +42.0% |
| Accounts Receivable | $85.9M | +29.2% |
| Current Assets | $325.6M | +6.3% |
| Total Assets | $442.6M | +6.5% |
| Current Liabilities | $176.7M | +23.8% |
| Total Liabilities | $217.7M | +26.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $34.7M | +4582.4% |
| Capital Expenditures | $2.1M | -45.8% |
| Investing Cash Flow | -$5.6M | +73.7% |
| Financing Cash Flow | -$33.7M | -96.3% |
| Free Cash Flow | $32.6M | +804.7% |
| +47.8% |
| EPS (Basic) | -$0.12 | +47.8% |
| Stockholders' Equity |
| $218.8M |
| -4.5% |